{"publication_id":"1747c75e-7396-47ed-9685-4f97bbb58d86","screening":{"identified":2,"screened":2,"excluded":0,"included":2,"included_or_retained":2,"flow":["identified","screened","excluded_with_reasons","included"],"wording":"2 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit.","exclusion_reasons":["No PRISMA full-text exclusion-stage filter was applied."]},"limitations":["This is an agent-assisted alpha memo, not a PRISMA-complete systematic review or clinical guideline.","It is not PROSPERO-registered and should not be read as medical advice.","Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."],"contradictions":["Across these trials, urolithin A improved multiple performance outcomes in middle-aged adults; in older adults, primary walk and ATP endpoints were null while muscle endurance improved. Because the cohorts and endpoints differed, this does not establish an age effect. [R1] [R2]"]}